These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
198 related items for PubMed ID: 4918921
1. [Effect of a decarboxylase inhibitor (Ro 4-4602) in combination with L-dopa on inhibited depressions]. Matussek N, Benkert O, Schneider K, Otten H, Pohlmeier H. Arzneimittelforschung; 1970 Jul; 20(7):934-5. PubMed ID: 4918921 [No Abstract] [Full Text] [Related]
2. [Effect of a decarboxylase inhibitor (Ro 4-4602) and L-dopa on inhibited depressions. II. Experimental psychological studies]. Pohlmeier H, Schön I, Matussek N. Arzneimittelforschung; 1970 Jul; 20(7):932-3. PubMed ID: 4918920 [No Abstract] [Full Text] [Related]
3. [Therapy of Parkinsonism using L-dopa in combination with a decarboxylase inhibitor]. Stammler A, Vielhaber K. Fortschr Neurol Psychiatr Grenzgeb; 1972 Oct; 40(10):564-8. PubMed ID: 4565521 [No Abstract] [Full Text] [Related]
4. Levodopa combined with MK 486 (L-alpha methyldopahydrazine)--a peripheral decarboxylase inhibitor in Parkinson's disease. Andrews CJ, Somerville B. Med J Aust; 1974 Mar 23; 1(12):429-32. PubMed ID: 4598384 [No Abstract] [Full Text] [Related]
5. [Advances in L-DOPA therapy for parkinsonism through combination with a decarboxylase inhibitor. Results of a long-term study]. Wälzholz U, Schönfelder H. Nervenarzt; 1972 Oct 23; 43(10):531-2. PubMed ID: 4628192 [No Abstract] [Full Text] [Related]
6. [Experiences in the treatment of Parkinson's disease with a combination drug: L-dopa plus decarboxylase inhibitor (Ro 8-0576)]. Steinhäusl H. Wien Med Wochenschr; 1973 Jun 30; 123(26):433-5. PubMed ID: 4578743 [No Abstract] [Full Text] [Related]
13. [Treatment of Parkinsonism with oral L-DOPA combined with a decarboxylase inhibitor (Ro IV 46.02)]. Tissot R, Gaillard JM, Guggisberg M, Gauthier G, de Ajuriaguerra J. Presse Med (1893); 1969 Apr 05; 77(17):619-22. PubMed ID: 5785081 [No Abstract] [Full Text] [Related]
14. [L-dopa therapy of Parkinson's syndrome. Comparison of pure L-dopa and the combination preparation L-dopa and decarboxylase inhibitor]. Görlich J, Markus E. Dtsch Med Wochenschr; 1972 Aug 25; 97(34):1246-8. PubMed ID: 5048316 [No Abstract] [Full Text] [Related]
15. Preliminary clinical experience with L-dopa in endogenous depressions. Náhunek K, Svestka J, Kamenická V, Rodová A. Act Nerv Super (Praha); 1972 Aug 25; 14(2):101-2. PubMed ID: 4557141 [No Abstract] [Full Text] [Related]
16. [Parkinson's syndrome. 4 years of experience in treatment with L Dopa associated with a decarboxylase inhibitor. Clinical and biochemical study]. Tissot R, de Ajuriaguerra J. Nouv Presse Med; 1973 Feb 03; 2(5):315-6. PubMed ID: 4686226 [No Abstract] [Full Text] [Related]
17. [Therapy of Parkinson's syndrome with L-dopa and a decarboxylase inhibitor (Ro 4-4602). Course in 71 patients]. Ferel D. Schweiz Med Wochenschr; 1972 Jan 22; 102(3):88-94. PubMed ID: 4551909 [No Abstract] [Full Text] [Related]
18. [Clinical studies on the treatment of parkinsonism with the L-dopa and decarboxylase inhibitor Ro-4-4602 association]. Wajsbort J, Hemli JA, Alfandary I, Yahel M, Siegfried J. Wien Med Wochenschr; 1971 Oct 16; 121(42):741-5. PubMed ID: 5115985 [No Abstract] [Full Text] [Related]